Phase 1 Ulcerative Colitis Clinical Trials
15 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–15 of 15 trials
Recruiting
Phase 1
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 1Phase 2
Superdonor FMT in Patients With Ulcerative Colitis
Active Ulcerative Colitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS42 enrolled1 locationNCT05739864
Recruiting
Phase 1Phase 2
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
Ulcerative ColitisClostridium Difficile
Fondazione Policlinico Universitario Agostino Gemelli IRCCS64 enrolled1 locationNCT06071312
Recruiting
Phase 1Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Xencor, Inc.270 enrolled40 locationsNCT06619990
Recruiting
Phase 1Phase 2
A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
Moderate to Severe Ulcerative Colitis
Genentech, Inc.24 enrolled1 locationNCT06693908
Recruiting
Phase 1
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Ulcerative ColitisUlcerative Colitis ChronicUlcerative Colitis Chronic Mild+1 more
Rise Therapeutics LLC36 enrolled4 locationsNCT05666960
Recruiting
Phase 1
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
Ulcerative Colitis (UC)
AltruBio Inc.24 enrolled1 locationNCT07350577
Recruiting
Phase 1Phase 2
A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited24 enrolled1 locationNCT07083193
Recruiting
Phase 1Phase 2
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Children's Hospital Medical Center, Cincinnati116 enrolled3 locationsNCT03847467
Recruiting
Phase 1Phase 2
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)
University Medical Center Groningen18 enrolled1 locationNCT06606808
Recruiting
Phase 1
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
Active Ulcerative ColitisActive Ulcerative Colitis (UC)Healthy Adult Volunteers
NIBEC Co., Ltd.24 enrolled1 locationNCT06681389
Recruiting
Phase 1
A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Ulcerative Colitis
Jiangsu Carephar Pharmaceutical Co., Ltd.64 enrolled1 locationNCT06627556
Recruiting
Phase 1
Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
Active Ulcerative Colitis (UC)
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT05786404
Recruiting
Phase 1
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Ulcerative Colitis
Children's Hospital Los Angeles10 enrolled1 locationNCT05218850
Recruiting
Phase 1Phase 2
Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
Crohn DiseaseUlcerative Colitis
University Medical Center Groningen21 enrolled1 locationNCT06117423